CLSA COVID-19 Studies

In response to coronavirus, the CLSA has launched three sub-studies to explore the impacts of the virus.

More than 28,000 CLSA participants have taken part in a questionnaire-based study to investigate the effects of the pandemic on older adults, exploring how they cope, the impacts on their physical and mental health and changes to how they access health-care services.

In fall 2020, a partnership with the COVID-19 Immunity Task Force launched the CLSA COVID-19 Antibody Study. This study collects and analyzes blood samples from more than 19,000 CLSA participants in 10 provinces to better understand how widespread SARS-CoV-2 infection is among adults over age 50. 

A third study, funded by the Canadian Institutes of Health Research, examines the impacts of SARS-CoV-2 on brain health.

COVID-19 Antibody Study

The CLSA COVID-19 Antibody Study collects and analyzes blood samples from more than 19,000 CLSA participants in 10 provinces. Study participants also complete a questionnaire, either by phone or online, that collects information about symptoms, risk factors, health-care use and the psychosocial and economic impacts of COVID-19.

Read More